Role of CD95-mediated adipocyte loss in autoimmune lipodystrophy

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 3, 2006, Pages 1129-1135

  Fischer Posovszky, Pamela ^a   Hebestreit, Helge ^b   Hofmann, Albert K ^c   Strauss, Gudrun ^a   Möller, Peter ^a   Debatin, Klaus Michael ^a   Wabitsch, Martin ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Clinic for Plastic Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BLOOD LEVEL; CASE REPORT; CELL LOSS; COMPLEX FORMATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; LIPODYSTROPHY; LYMPHOCYTIC INFILTRATION; PANNICULITIS; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROADIPOCYTE; RARE DISEASE; SENSITIZATION; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; CELL CULTURE TECHNIQUES; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; LIPODYSTROPHY;

EID: 33644825988     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0737     Document Type: Article

References (34)

1. Garg A 2004 Acquired and inherited lipodystrophies. N Engl J Med 350:1220-1234
2. Misra A, Garg A 2003 Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine (Baltimore) 82:129-146
3. Billings JK, Milgraum SS, Gupta AK, Headington JT, Rasmussen JE 1987 Lipoatrophic panniculitis: a possible autoimmune inflammatory disease of fat. Report of three cases. Arch Dermatol 123:1662-1666
4. Hubler A, Abendroth K, Keiner T, Stocker W, Kauf E, Hein G, Stein G 1998 Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence syndrome) connected with autoantibodies against adipocyte membranes. Exp Clin Endocrinol Diabetes 106:79-84
5. Jasin HE 1979 Systemic lupus erythematosus, partial lipodystrophy and hypocomplementia. J Rheumatol 6:43-50
6. Torrelo A, Espana A, Boixeda P, Ledo A 1991 Partial lipodystrophy and dermatomyositis. Arch Dermatol 127:1846-1847
7. Salmaso C, Bagnasco M, Pesce G, Montagna P, Brizzolara R, Altrinetti V, Richiusa P, Galluzzo A, Giordano C 2002 Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. Ann NY Acad Sci 966:496-501
8. Savinov AY, Tcherepanov A, Green EA, Flavell RA, Chervonsky AV 2003 Contribution of Fas to diabetes development. Proc Natl Acad Sci USA 100:628-632
9. Fischer-Posovszky P, Tornqvist H, Debatin KM, Wabitsch M 2004 Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)/IGF-I receptor autocrine circuit. Endocrinology 145:1849-1859
10. Strater J, Walczak H, Krammer PH, Moller P 1996 Simultaneous in situ detection of mRNA and apoptotic cells by combined hybridization and TUNEL. J Histochem Cytochem 44:1497-1499
11. Wabitsch M, Brenner RE, Melzner I, Braun M, Moller P, Heinze E, Debatin KM, Hauner H 2001 Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord 25:8-15
12. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH 1989 Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305
13. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C 1991 A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279
14. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A 1997 Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963
15. Loweth AC, Williams GT, James RF, Scarpello JH, Morgan NG 1998 Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1β and Fas ligation. Diabetes 47:727-732
16. Bernassola F, Scheuerpflug C, Herr I, Krammer PH, Debatin KM, Melino G 1999 Induction of apoptosis by IFNγ in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit. Cell Death Differ 6:652-660
17. Nagata S, Golstein P 1995 The Fas death factor. Science 267:1449-1456
18. Krammer PH 2000 CD95's deadly mission in the immune system. Nature 407:789-795
19. Prins JB, Walker NI, Winterford CM, Cameron DP 1994 Human adipocyte apoptosis occurs in malignancy. Biochem Biophys Res Commun 205:625-630
20. Domingo P, Matias-Guiu X, Pujol RM, Francia E, Lagarda E, Sambeat MA, Vazquez G 1999 Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS 13:2261-2267
21. Domingo P, Matias-Guiu X, Pujol RM, Domingo JC, Arroyo JA, Sambeat MA, Vazquez G 2001 Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy. J Infect Dis 184:1197-1201
22. Lloreta J, Domingo P, Pujol RM, Arroyo JA, Baixeras N, Matias-Guiu X, Gilaberte M, Sambeat MA, Serrano S 2002 Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy. Virchows Arch 441:599-604
23. Charriere G, Cousin B, Arnaud E, Andre M, Bacou F, Penicaud L, Casteilla L 2003 Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 278:9850-9855
24. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, Moller P 1993 Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69:415-429
25. Ahn EY, Pan G, Vickers SM, McDonald JM 2002 IFN-γ upregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. Int J Cancer 100:445-451
26. Shin EC, Shin WC, Choi Y, Kim H, Park JH, Kim SJ 2001 Effect of interferon-γ on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells. Cancer Immunol Immunother 50:23-30
27. Kimura M, Haisa M, Uetsuka H, Takaoka M, Ohkawa T, Kawashima R, Yamatsuji T, Gunduz M, Kaneda Y, Tanaka N, Naomoto Y 2003 TNF combined with IFN-α accelerates NF-κB-mediated apoptosis through enhancement of Fas expression in colon cancer cells. Cell Death Differ 10:718-728
28. Matsumura R, Umemiya K, Goto T, Nakazawa T, Ochiai K, Kagami M, Tomioka H, Tanabe E, Sugiyama T, Sueishi M 2000 Interferon γ and tumor necrosis factor α induce Fas expression and anti-Fas mediated apoptosis in a salivary ductal cell line. Clin Exp Rheumatol 18:311-318
29. Riccioli A, Starace D, D'Alessio A, Starace G, Padula F, De Cesaris P, Filippini A, Ziparo E 2000 TNF-α and IFN-γ regulate expression and function of the Fas system in the seminiferous epithelium. J Immunol 165:743-749
30. Wachlin G, Augstein P, Schroder D, Kuttler B, Kloting I, Heinke P, Schmidt S 2003 IL-1β, IFN-γ and TNF-α increase vulnerability of pancreatic β cells to autoimmune destruction. J Autoimmun 20:303-312
31. Kim KB, Choi YH, Kim IK, Chung CW, Kim BJ, Park YM, Jung YK 2002 Potentiation of Fas- and TRAIL-mediated apoptosis by IFN-γ in A549 lung epithelial cells: enhancement of caspase-8 expression through IFN-response element. Cytokine 20:283-288
32. Strauss G, Knape I, Melzner I, Debatin KM 2003 Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated antigen-specific T cells. J Immunol 171:1172-1182
33. Suzuki A, Hayashida M, Kawano H, Sugimoto K, Nakano T, Shiraki K 2000 Hepatocyte growth factor promotes cell survival from Fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression. Hepatology 32:796-802
34. Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS 2004 IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC. Oncogene 12:6083-6094